Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergoogle.com
Google Alert - HER2-ADC
Get the latest updates from Google Alert - HER2-ADC directly as they happen.
Follow now 124 followers
Latest posts
Last updated about 14 hours ago
Bio-Thera advances CD25-targeted ADC into first human trial for solid tumors. - AllSci
about 16 hours ago
... HER2- and Trop2-directed ADCs that dominate the current landscape. The announcement...
Nabil Ismaili: The Era of Precision Oncology in Urothelial Carcinoma Has Truly Arrived
1 day ago
The combination of disitamab vedotin (anti-HER2 ADC) plus toripalimab (anti-PD-1) has demonstrated...
EU panel endorses label upgrades for Trodelvy, Enhertu in 1L breast cancer
3 days ago
CHMP also adopted a positive opinion for AstraZeneca and Daiichi Sankyo's HER2-targeting...
Enhertu plus pertuzumab recommended for approval in the EU by CHMP as 1st-line ... - Cision News
4 days ago
Enhertu is a HER2-directed ADC. Designed using Daiichi Sankyo's proprietary DXd ADC...
Enhertu® Plus Pertuzumab Recommended for Approval in the EU by CHMP as ... - Yahoo Finance
4 days ago
... HER2 directed ADC. Designed using Daiichi Sankyo's proprietary DXd ADC Technology...
Changing ADC Choices for HR+/HER2–Breast Cancer | Targeted Oncology
4 days ago
The recent arrival of antibody-drug conjugates (ADCs) active in HER2-low and even...
Advancing antibody drug conjugates in gastrointestinal cancers | British Journal of Cancer
4 days ago
DS-8201a, a novel HER2-targeting ADC with a novel DNA topoisomerase I...
Qurient: Dual Payload ADC 'QP101' Shows Higher Response Rate Than Enhertu
5 days ago
Qurient announced on July 23 that it released the results of the...
Click Chemistry Boosts Antibody–Drug Conjugates Against Heterogeneous Tumors
5 days ago
ADC recognizes only single molecular target, many cancers become ... ” strategy...
Henlius Expands Clinical Development of AbClon-Derived HER2 Antibody AC101 in Breast Cancer
6 days ago
The post indicates that Henlius has initiated a Phase 2/3 trial combining...
Click Chemistry Boosts Antibody–Drug Conjugates Against Heterogeneous Tumors
6 days ago
Researchers at Washington University School of Medicine modified FDA-approved antibodies and HER2-directed...
EGFR Exon 20 and HER2-Deregulated NSCLC: The Rare Lung Cancer Subtypes Moving ...
7 days ago
EGFR exon 20 HER2 NSCLC treatment is evolving with amivantamab, new TKIs...